Abstract:The retinoid X receptor (RXR) heterodimerizes with a variety of nuclear receptors. In addition, RXR forms homodimers in the presence of its ligand, 9-cis-retinoic acid. From deletion and point mutation analysis we present evidence that a short region (amino acids 413 to 443) in the carboxy terminus of RXR alpha is critical for both homo- and heterodimeric interactions as well as for diverse functional activities. In addition, we present evidence that homo- and heterodimer functions can be separated. The deletion of 19 amino acids from the C-terminal end of RXR dramatically reduced the transcriptional activation function of RXR. The removal of 10 additional amino acids resulted in a receptor (delta RXR3) that had completely lost its ligand-dependent homodimer function but retained its heterodimer activities. Heterodimer function was abolished by the deletion of an additional 20 amino acids. Single amino acid substitutions in the region generated receptors with altered RXR homodimer DNA binding, while simultaneous mutation of three Leu residues (Leu-418, -419 and -422) completely abolished both RXR homodimer and heterodimer DNA binding activities. Mutation of Leu-430 to Phe (L430-F) resulted in a receptor that bound to DNA strongly as homodimers in a ligand-independent manner, while another single amino acid exchange (L422-Q) led to a mutant that behaved in a manner exactly opposite to that of wild-type RXR in that the homodimerization of the mutant occurred in the absence of ligand and was inhibited by 9-cis-retinoic acid. In transfection assays, both L422-Q and L430-F failed to act as homodimers but retained their heterodimer function. Our studies demonstrate the unique properties of the RXR ligand binding domain and point to specific residues that mediate homo- and heterodimer activities and ligand-induced conformational switches.

Homodimer Formation of Retinoid X Receptor Induced by 9-Cis Retinoic Acid

Structural Basis for Retinoic X Receptor Repression on the Tetramer

Mutations That Alter Ligand-induced Switches and Dimerization Activities in the Retinoid X Receptor

Regulation of Retinoid and Thyroid Hormone Action Through Homodimeric and Heterodimeric Receptors

Formation of Retinoid X Receptor Homodimers Leads to Repression of T3 Response: Hormonal Cross Talk by Ligand-Induced Squelching.

Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer.

Retinoid X Receptor is an Auxiliary Protein for Thyroid Hormone and Retinoic Acid Receptors.

Mutation of Two Residues Converts the Ligand-Binding Domain of RXRα into a Uniform Monomer Without Impairing the Binding of Retinoic Acid and Cofactors.

Danthron Functions as a Retinoic X Receptor Antagonist by Stabilizing Tetramers of the Receptor

Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.

Hetero- and homodimeric receptors in thyroid hormone and vitamin A action.

Retinoid X Receptor Heterodimers in Hepatic Function: Structural Insights and Therapeutic Potential

Ligand Binding and Heterodimerization with Retinoid X Receptor Α (rxrα) Induce Farnesoid X Receptor (FXR) Conformational Changes Affecting Coactivator Binding

Discovery and Design of Retinoic Acid Receptor and Retinoid X Receptor Class- and Subtype-Selective Synthetic Analogs of All-Trans-retinoic Acid and 9-Cis-retinoic Acid.

Determinants of retinoid X receptor transcriptional antagonism.

A decade of molecular biology of retinoic acid receptors

The Effect of Antagonists on the Conformational Exchange of the Retinoid X Receptor Alpha Ligand-Binding Domain

A Structure-based Approach to Retinoid X Receptor-α Inhibition

Structural Basis of the Farnesoid X Receptor/retinoid X Receptor Heterodimer on Inverted Repeat DNA

Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells.

Comparison of phenotypic and global gene expression changes in Xenopus tropicalis embryos induced by agonists of RAR and RXR.